Lv41
610 积分 2021-10-27 加入
Cancer Treatment–Related Complications in Patients With Hypertrophic Cardiomyopathy
5小时前
已关闭
Mavacamten and Aficamten in Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Trials
5天前
已完结
Cardiac Chamber‐Specific Regulation of Myosin Biochemical Super‐Relaxation and Auto‐Inhibition
6天前
已完结
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
12天前
已完结
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
1个月前
已完结
Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress Using NT-proBNP: A Clinical Consensus Statement from the Heart Failure Association of the ESC
1个月前
已完结
Feature Tracking–Derived Global Longitudinal Strain Enhances Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy
1个月前
已完结
Validation of the HCM Risk‐SCD model in patients with hypertrophic cardiomyopathy and future perspectives
1个月前
已完结
Incidence of newly recognized atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy treated with Mavacamten
1个月前
已完结
皖公网安备34019202002308
